The order eases restrictions on psychedelic drugs like ibogaine to spur research on using the them for medical purposes.

The executive order will open the door for more research into the psychedelic drug ibogaine, sources told CBS News earlier ...

The order instructs the FDA to expedite review of drugs such as ibogaine, a drug that veterans' groups have said can help ...

This article examines emerging non-opioid strategies for chronic pain, from targeted ion-channel drugs and anti-inflammatory ...

The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...

Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...

Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB ...

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...

It’s been a little over two months since President Donald Trump’s direct-to-consumer pharmaceutical site, TrumpRx, launched, ...

WILMINGTON, DE — AstraZeneca (NYSE: AZN) said its experimental drug tozorakimab reduced moderate-to-severe exacerbations in ...

Alto Neurosciences is halting work on its schizophrenia prospect after the brain-penetrant drug flunked a phase 2 study. The Bay Area biotech evaluated 10 days of treatment with the ...

An inexpensive blood pressure drug could improve the health of cancer patients, according to a recent preclinical study. The drug, telmisartan, is FDA-approved to treat hypertension (high blood ...